Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Gross Margin

Aquestive Therapeutics Inc Gross Margin Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Gross Margin from 2006 to 2018. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Aquestive Therapeutics Inc Gross Margin for the quarter ending December 12, 2018 was $72m a -6.12% decrease of -4m year over year
  • Aquestive Therapeutics Inc Gross Margin for the last 12 months ending December 12, 2018 was $69m a -3.39% decrease of -2m year over year
  • Aquestive Therapeutics Inc Annual Gross Margin for 2018 was $69m a -2.19% decrease of -2m from 2017
  • Aquestive Therapeutics Inc Annual Gross Margin for 2017 was $70m a 2.85% increase of 2m from 2016
  • Aquestive Therapeutics Inc Annual Gross Margin for 2016 was $68m a 41.17% increase of 28m from 2015
Other Margins & Efficiency Metrics:
  • Aquestive Therapeutics Inc EBITDA Margin for the quarter ending December 12, 2018 was $-69m a 139.08% decrease of -96m year over year
  • Aquestive Therapeutics Inc Return on Capital % for the quarter ending December 12, 2018 was -48.42 a -5.35% increase of 2.59 year over year
  • Aquestive Therapeutics Inc Return on Equity % for the quarter ending December 12, 2018 was -332.75
View Chart On Koyfin

Quarterly AQST Gross Margin Data

12/2018$72m
09/2018$58m
06/2018$64m
03/2018$76m
12/2017$54m
09/2017$82m
06/2017$54m
03/2017$75m
06/2007$49m
03/2007$51m

Annual AQST Gross Margin Data

2018$69m
2017$70m
2016$68m
2006$40m
2005$40m
2004$32m